📊 DH Key Takeaways
Is Definitive Healthcare Corp. (DH) a Good Investment?
Definitive Healthcare faces severe operational distress with a -359.9% operating margin despite strong 74.5% gross margins, indicating structural cost problems masking deteriorating fundamentals. Revenue contraction of 4.2% YoY combined with $154M debt and inability to cover interest from operations creates an unsustainable financial structure requiring urgent restructuring.
Definitive Healthcare shows a fundamentally mixed profile: strong gross margins and positive free cash flow indicate the core software model still has economic value, and liquidity appears adequate. However, declining revenue, deeply negative operating and net margins, and weak interest coverage point to a business that is not converting its gross profit into durable earnings. Until the company restores consistent top-line growth and materially improves operating leverage, the fundamentals remain weak.
Definitive Healthcare Corp. Key Strengths (DH)
- Strong gross margin of 74.5% indicates viable underlying product economics and pricing power
- Positive operating cash flow of $11.6M and free cash flow of $8.4M despite net losses suggests non-cash charges rather than operational cash burn
- Adequate liquidity with $157.6M cash and current ratio of 1.75x provides short-term solvency buffer
- High gross margin of 75.9% suggests attractive unit economics in the core software business
- Positive operating cash flow of $53.78M and free cash flow of $37.06M support near-term financial flexibility
- Solid liquidity and moderate leverage with a 1.64x current ratio, $163.63M cash, and 0.44x debt-to-equity
DH Stock Risks: Definitive Healthcare Corp. Investment Risks
- Revenue declining 4.2% YoY with negative operating margin of -359.9% signals fundamental business model deterioration and inability to scale profitably
- Cannot service debt from operations with -76.6x interest coverage ratio; highly leveraged at $154M debt against contracting revenue base
- Massive non-cash charges resulting in -$138.6M net loss likely reflect goodwill impairment or acquisition-related amortization, indicating prior strategic missteps
- Revenue declined 4.2% YoY, raising concern about demand durability and growth quality
- Operating margin of -92.9% shows severe cost structure or charge-related pressure that overwhelms gross profit
- Negative interest coverage and sizable net losses indicate weak earnings support for debt obligations
Key Metrics to Watch
- Revenue trajectory and customer retention rates to confirm if contraction stabilizes or accelerates
- Operating expenses as percentage of revenue and management's restructuring progress to restore margin sustainability
- Cash burn runway and covenant compliance against debt obligations given negative profitability and declining revenue
- Revenue growth reacceleration and customer retention/expansion trends
- Operating margin improvement and sustained free cash flow conversion
Definitive Healthcare Corp. (DH) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Definitive Healthcare Corp. presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.
DH Profit Margin, ROE & Profitability Analysis
DH vs Technology Sector: How Definitive Healthcare Corp. Compares
How Definitive Healthcare Corp. compares to Technology sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Definitive Healthcare Corp. Stock Overvalued? DH Valuation Analysis 2026
Based on fundamental analysis, Definitive Healthcare Corp. shows some fundamental concerns relative to the Technology sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Definitive Healthcare Corp. Balance Sheet: DH Debt, Cash & Liquidity
DH Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Definitive Healthcare Corp.'s revenue has grown significantly by 52% over the 5-year period, indicating strong business expansion. The most recent EPS of $-1.79 indicates the company is currently unprofitable.
DH Revenue Growth, EPS Growth & YoY Performance
DH Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $55.9M | -$107.2M | $-0.95 |
| Q3 2025 | $60.0M | -$14.8M | $-0.14 |
| Q2 2025 | $60.8M | -$7.6M | $-0.07 |
| Q1 2025 | $59.2M | -$9.5M | $-0.08 |
| Q3 2024 | $62.7M | -$130.9M | $-1.12 |
| Q2 2024 | $61.0M | -$8.6M | $-0.08 |
| Q1 2024 | $59.2M | -$9.5M | $-0.08 |
| Q3 2023 | $57.4M | -$3.0M | $-0.03 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Definitive Healthcare Corp. Dividends, Buybacks & Capital Allocation
DH SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Definitive Healthcare Corp. (CIK: 0001861795)
📋 Recent SEC Filings
❓ Frequently Asked Questions about DH
What is the AI rating for DH?
Definitive Healthcare Corp. (DH) has a Combined AI Grade of C from Claude (D) and ChatGPT (C) with 82% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are DH's key strengths?
Claude: Strong gross margin of 74.5% indicates viable underlying product economics and pricing power. Positive operating cash flow of $11.6M and free cash flow of $8.4M despite net losses suggests non-cash charges rather than operational cash burn. ChatGPT: High gross margin of 75.9% suggests attractive unit economics in the core software business. Positive operating cash flow of $53.78M and free cash flow of $37.06M support near-term financial flexibility.
What are the risks of investing in DH?
Claude: Revenue declining 4.2% YoY with negative operating margin of -359.9% signals fundamental business model deterioration and inability to scale profitably. Cannot service debt from operations with -76.6x interest coverage ratio; highly leveraged at $154M debt against contracting revenue base. ChatGPT: Revenue declined 4.2% YoY, raising concern about demand durability and growth quality. Operating margin of -92.9% shows severe cost structure or charge-related pressure that overwhelms gross profit.
What is DH's revenue and growth?
Definitive Healthcare Corp. reported revenue of $55.9M.
Does DH pay dividends?
Definitive Healthcare Corp. does not currently pay dividends.
Where can I find DH SEC filings?
Official SEC filings for Definitive Healthcare Corp. (CIK: 0001861795) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is DH's EPS?
Definitive Healthcare Corp. has a diluted EPS of $-1.32.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is DH's fundamental grade?
Based on our AI fundamental analysis in June 2026, Definitive Healthcare Corp. has a C grade with 82% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is DH stock overvalued or undervalued?
Valuation metrics for DH: ROE of -72.7% (sector avg: 22%), net margin of -247.9% (sector avg: 18%). Compare these metrics with sector averages to assess valuation.
What is DH's AI grade for 2026?
Our dual AI analysis gives Definitive Healthcare Corp. a combined C grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is DH's free cash flow?
Definitive Healthcare Corp.'s operating cash flow is $11.6M, with capital expenditures of $3.2M. FCF margin is 15.0%.
How does DH compare to other Technology stocks?
Vs Technology sector averages: Net margin -247.9% (avg: 18%), ROE -72.7% (avg: 22%), current ratio 1.75 (avg: 2.5).